Mitchener Stephen
- SEC CIK
- 0001774519
No open-market purchases or sales filed in the past year.
Current role at each company
- KPTI Karyopharm Therapeutics Inc.SVP, Chief Business Officeras of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mitchener Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 (view filing) | Mar 1 | 1 day | Mitchener StephenSVP, Chief Business Officer | SSale | −6.36K | $3.03 | −$19.3K | −4.7%128.3K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Mitchener StephenSVP, Chief Business Officer | SSale | −499 | $6.69 | −$3.34K | −13.1%3.30K after |